Looking for reasons to celebrate during the fourth-quarter profit season? A few standout S&P 500 companies just gave you some big ones.
Last year, shares in Advanced Micro Devices (NASDAQ: AMD) fell 55%, alongside steep declines in the PC market. The company's data center segment has proven its strength in recent quarters, giving the tech giant a promising outlook. AMD's PC-driven segments faltered over the last year, but its data center business generated the most revenue and growth.
The defensiveness and stability of these stocks may be underrated but could be more valuable than many investors think.
This year’s gains owe to an expansion in stocks’ price/earnings multiples. Meanwhile, earnings estimates are falling.
Wells Fargo, Bristol Myers, Darden Restaurants, Webster Financial and Prudential Financial are balanced in returning capital through dividends and buybacks.
It might be obvious to point out that an important part of the investing game is to find the stocks that are undervalued — that is, the companies with sound fundamentals that the market is presently not fully appreciating. Luckily for investors, after 2022’s widespread carnage, there are still plenty of names out there still at relatively depressed levels. In fact, even after the strong rallies seen in the year’s opening stretch, such was 2022’s merciless bear, there are scores of stocks out the
Financial technology, or fintech stocks, have been some of the worst performers in the bear market. The industry has been hit extremely hard overall, as investors fear the effects of a recession on consumer spending, credit quality, small businesses, and more. Two in particular that look interesting right now are Bill.com (NYSE: BILL) and Marqeta (NASDAQ: MQ).
The first step to successful investing is to know your target companies inside and out. Then you can take advantage of opportunities others might miss.
One of these players offers major growth prospects; the other has delivered decades of passive income growth.
Three on the top of my list of stocks I will (probably) never sell are law enforcement and security company Axon Enterprise (NASDAQ: AXON), Walt Disney (NYSE: DIS), and Apple (NASDAQ: AAPL). The company at the center of body camera footage we see today is Axon, but that's only a piece of the business. It started as the Taser manufacturer, moved to body cameras, and is now a cloud software company that catalogs crime reports.
Silvergate Capital, Riot Blockchain and Coinbase have been highlighted in this Investment Ideas article.
Investment management company RGA Investment Advisors recently released its fourth-quarter 2022 investor letter. A copy of the same can be downloaded here. 2022 was a difficult year for the market and forecasting business trends and opportunities were challenging. The firm focuses on growing companies, at reasonable valuations with demonstrable business quality. The firm also believes […]
To get a sense of who is truly in control of Enphase Energy, Inc. ( NASDAQ:ENPH ), it is important to understand the...
Using technical analysis of the charts of those stocks, and, when appropriate, recent actions and grades from TheStreet's Quant Ratings, we zero in on three names. While we will not be weighing in with fundamental analysis, we hope this piece will give investors interested in stocks on the way down a good starting point to do further homework on the names. Sysco Corp. is rated is rated a Hold with a C+ rating by TheStreet's Quant Ratings.
Gautam Adani an Indian businessman, is one of the richest people in the world. Here is what you need to know about the Adani saga. There are seven India-listed companies bearing the Adani name, including firms in power transmission, green energy and port operation.
Ardelyx, Inc. ( NASDAQ:ARDX ) is possibly approaching a major achievement in its business, so we would like to shine...
U.S. stock futures pointed to a second day of losses after an unexpectedly strong jobs report renewed worries about how high the Federal Reserve will have to take interest rates.
In this article, we discuss top 25 dividend challengers by yield. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read Dividend Challengers List Ranked By Yield: Top 10. Dividend Challengers are companies that have raised their dividends for five years or more. These companies […]
These stocks have already increased significantly in 2023, and the trend appears poised to continue.
Shares of Gilead Sciences (NASDAQ: GILD) marched higher on Thursday, Feb. 2 in response to a fourth-quarter earnings report that exceeded expectations. A day later, the U.S. Food and Drug Administration (FDA) agreed to dramatically increase the addressable patient population for an important cancer drug called Trodelvy. Gilead Sciences splashed out with a $21 billion acquisition of Immunomedics in 2020 for access to Trodelvy.